Oryzon Genomics: Audience

Oryzon Genomics is a clinical stage biopharmaceutical company focused on developing innovative epigenetic personalized medicines for patients suffering from cancer and central nervous system (CNS) disorders. The company leverages its epigenetic platform to discover and develop targeted therapeutics that address significant unmet medical needs.